485 related articles for article (PubMed ID: 22069560)
1. Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer.
Yadav VR; Prasad S; Sung B; Kannappan R; Aggarwal BB
Toxins (Basel); 2010 Oct; 2(10):2428-66. PubMed ID: 22069560
[TBL] [Abstract][Full Text] [Related]
2. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer.
Shanmugam MK; Nguyen AH; Kumar AP; Tan BK; Sethi G
Cancer Lett; 2012 Jul; 320(2):158-70. PubMed ID: 22406826
[TBL] [Abstract][Full Text] [Related]
3. Triterpenoids as new promising anticancer drugs.
Petronelli A; Pannitteri G; Testa U
Anticancer Drugs; 2009 Nov; 20(10):880-92. PubMed ID: 19745720
[TBL] [Abstract][Full Text] [Related]
4. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.
Prasad S; Yadav VR; Sung B; Reuter S; Kannappan R; Deorukhkar A; Diagaradjane P; Wei C; Baladandayuthapani V; Krishnan S; Guha S; Aggarwal BB
Clin Cancer Res; 2012 Sep; 18(18):4942-53. PubMed ID: 22832932
[TBL] [Abstract][Full Text] [Related]
5. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
Sethi G; Ahn KS; Pandey MK; Aggarwal BB
Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449
[TBL] [Abstract][Full Text] [Related]
6. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.
Aggarwal BB; Vijayalekshmi RV; Sung B
Clin Cancer Res; 2009 Jan; 15(2):425-30. PubMed ID: 19147746
[TBL] [Abstract][Full Text] [Related]
7. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
Shanmugam MK; Rajendran P; Li F; Nema T; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Ho PC; Hui KM; Sethi G
J Mol Med (Berl); 2011 Jul; 89(7):713-27. PubMed ID: 21465181
[TBL] [Abstract][Full Text] [Related]
8. Cancer chemopreventive activity of maslinic acid: suppression of COX-2 expression and inhibition of NF-κB and AP-1 activation in Raji cells.
Hsum YW; Yew WT; Hong PL; Soo KK; Hoon LS; Chieng YC; Mooi LY
Planta Med; 2011 Jan; 77(2):152-7. PubMed ID: 20669087
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evidences for cytotoxic and antitumor properties of Boswellic acids from Boswellia serrata.
Khan MA; Ali R; Parveen R; Najmi AK; Ahmad S
J Ethnopharmacol; 2016 Sep; 191():315-323. PubMed ID: 27346540
[TBL] [Abstract][Full Text] [Related]
10. Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer.
Kannaiyan R; Shanmugam MK; Sethi G
Cancer Lett; 2011 Apr; 303(1):9-20. PubMed ID: 21168266
[TBL] [Abstract][Full Text] [Related]
11. Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies.
Shanmugam MK; Dai X; Kumar AP; Tan BK; Sethi G; Bishayee A
Biochem Pharmacol; 2013 Jun; 85(11):1579-87. PubMed ID: 23499879
[TBL] [Abstract][Full Text] [Related]
12. Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy.
Laszczyk MN
Planta Med; 2009 Dec; 75(15):1549-60. PubMed ID: 19742422
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
[TBL] [Abstract][Full Text] [Related]
14. [Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases].
Ammon HP
Wien Med Wochenschr; 2002; 152(15-16):373-8. PubMed ID: 12244881
[TBL] [Abstract][Full Text] [Related]
15. Triterpenoids for cancer prevention and treatment: current status and future prospects.
Patlolla JM; Rao CV
Curr Pharm Biotechnol; 2012 Jan; 13(1):147-55. PubMed ID: 21466427
[TBL] [Abstract][Full Text] [Related]
16. Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends.
Tuli HS; Rath P; Chauhan A; Ranjan A; Ramniwas S; Sak K; Aggarwal D; Kumar M; Dhama K; Lee EHC; Yap KC; Capinpin SM; Kumar AP
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671442
[TBL] [Abstract][Full Text] [Related]
17. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
Tu Y; Tan F; Zhou J; Pan J
Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
[TBL] [Abstract][Full Text] [Related]
18. Celastrol and Its Role in Controlling Chronic Diseases.
Venkatesha SH; Moudgil KD
Adv Exp Med Biol; 2016; 928():267-289. PubMed ID: 27671821
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid.
Lee JH; Koo TH; Yoon H; Jung HS; Jin HZ; Lee K; Hong YS; Lee JJ
Biochem Pharmacol; 2006 Nov; 72(10):1311-21. PubMed ID: 16984800
[TBL] [Abstract][Full Text] [Related]
20. Ganoderic acids suppress growth and angiogenesis by modulating the NF-κB signaling pathway in breast cancer cells.
Li F; Wang Y; Wang X; Li J; Cui H; Niu M
Int J Clin Pharmacol Ther; 2012 Oct; 50(10):712-21. PubMed ID: 22762853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
